ARS Pharmaceuticals shares are trading higher after Director Rajeev Shah acquired a total of 2,700,000 shares an average price of $3.03 for roughly $8.18 million.
Portfolio Pulse from Benzinga Newsdesk
ARS Pharmaceuticals Director Rajeev Shah has acquired a total of 2,700,000 shares at an average price of $3.03, amounting to roughly $8.18 million. This has led to a rise in the company's share prices.
September 26, 2023 | 2:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Director Rajeev Shah's acquisition of 2,700,000 shares has led to a rise in ARS Pharmaceuticals' share prices.
Insider trading, especially when it involves large quantities of shares, often signals confidence in the company's future prospects. This can lead to increased investor confidence and a rise in share prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100